Skip to main content
Clinical Trials/NCT00474448
NCT00474448
Completed
N/A

The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses

University of British Columbia1 site in 1 country200 target enrollmentMay 2007

Overview

Phase
N/A
Intervention
Not specified
Conditions
Exostoses, Multiple Hereditary
Sponsor
University of British Columbia
Enrollment
200
Locations
1
Primary Endpoint
SF-36 score for adults and CHQ PF-50 for children
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to assess the health-related quality of life of subjects who have Hereditary Multiple Exostoses and to develop a disease specific quality of life survey. The investigators hypothesize that there are a wide range of quality of life experiences for patients with this syndrome.

Detailed Description

At the time of recruitment, subjects will be asked to indicate whether they would like to participate in a one-time survey, or are willing to participate in the initial survey plus two additional questionnaire administrations, thereafter, which will be used to develop the disease-specific quality of life (QOL) score. All participants will complete either the SF-36 survey (for adult HME subjects) or the CHQ PF (for parents of children with HME), as applicable, in addition to a blank form with categorical subheadings (such as recreation, social function, etc.), which they will use to address any issues not covered in the standardized questionnaire. Standardized questionnaires will be scored and analyzed. The items listed on the second form will be compiled and reapplied to subjects that indicated interest in extended participation in survey completion. Subjects will be asked to determine which items apply to them and to rank these applicable items in order of importance. The results from this will be used to develop a 30 question, disease-specific questionnaire. The final step will be to readminister this survey, in conjunction with the SF-36 or CHQ PF, and follow up, in two weeks, with a second administration of the aforementioned surveys, in order to test the variability and validity of the disease-specific, health-related, quality of life score.

Registry
clinicaltrials.gov
Start Date
May 2007
End Date
February 2014
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Christine Alvarez

Principle Investigator

University of British Columbia

Eligibility Criteria

Inclusion Criteria

  • Must be diagnosed with Hereditary Multiple Exostoses
  • Adult patients or parents of child patients

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

SF-36 score for adults and CHQ PF-50 for children

Time Frame: No time frame

Study Sites (1)

Loading locations...

Similar Trials